IN DEPTH

Digitising the pharma supply chain

Shaking up the schizophrenia drug landscape

Could supercomputers transform pharma R&D?

Supply chain

 The dark consequences of supply shortages

Where failing supply chains leave patients short of medicines, illegal online pharmacies provide a dangerous solution

DATA

Making sense of Covid-19 vaccine pricing policies

Mental health

Could psychedelics shake up mental health treatment?

Digitising the pharma supply chain

Shaking up the schizophrenia drug landscape

Could supercomputers transform pharma R&D?

02/24/2024 04:20:38
  • Home | Drug dealing goes digital 
  • In this issue
  • Contents
  • Syrenis
  • Astrix
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • Thermo Fisher Scientific Company Insight
  • Thermo Fisher Scientific
  • Comment
  • Life sciences professionals prioritise quality over cost for PV automation
  • Slow progress for male contraceptive trials
  • Accelerated approval designations in China
  • Mimotopes Company Insight
  • Mimotopes
  • In Depth
  • The dark consequences of supply shortages
  • Digitising the pharma supply chain
  • Covid-19 vaccine pricing varies wildly by country and company 
  • Psychedelics and mental health: the next big thing?
  • Schizophrenia drug landscape: a stagnant field on the cusp of change?
  • Are supercomputers set to transform pharma R&D?
  • BEA Technologies
  • Labcorp
  • In Data
  • North America's AI hiring boom
  • The pharma companies leading the way in artificial intelligence
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Events
  • Next issue
11/18/2021 00:00:00